MedTrace Logo

Implantation of a Trifocal Hydrophobic IOL in Patients That Underwent Refractive Surgery

NCT04054427 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-10-07

No results posted yet for this study

Summary

Controlled, open label, prospective Post Market Clinical Follow-Up, single-center clinical study to investigate visual performance after implantation of a trifocal IOL (PhysIOL Pod L GF) in patients that underwent refractive surgery.

Conditions

Interventions

DEVICE

IOL implantation experimental

Implantation of trifocal IOL POD L GF consisting of hydrophobic material

Sponsors & Collaborators

  • Beaver-Visitec International, Inc.

    lead INDUSTRY

Principal Investigators

  • Béatrice Cochener, Prof · Département d'ophtalmologie - CHU Morvan Bâtiment 4 bis

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2022-05-31
Completion
2022-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04054427 on ClinicalTrials.gov